124 related articles for article (PubMed ID: 19205324)
1. Management of pelvic giant cell tumours involving the acetabular bone.
Donati D; Wafa H; Di Bella C; Colangeli M; Colangeli S; Bertoni F
Acta Orthop Belg; 2008 Dec; 74(6):773-8. PubMed ID: 19205324
[TBL] [Abstract][Full Text] [Related]
2. Extended intralesional curettage preferred over resection-arthrodesis for giant cell tumour of the distal radius.
Abuhejleh H; Wunder JS; Ferguson PC; Isler MH; Mottard S; Werier JA; Griffin AM; Turcotte RE
Eur J Orthop Surg Traumatol; 2020 Jan; 30(1):11-17. PubMed ID: 31297594
[TBL] [Abstract][Full Text] [Related]
3. The outcomes of treatment of giant cell tumor of bone around the knee.
Asavamongkolkul A; Eamsobhana P; Waikakul S; Phimolsarnti R
J Med Assoc Thai; 2012 Sep; 95 Suppl 9():S122-8. PubMed ID: 23326994
[TBL] [Abstract][Full Text] [Related]
4. Treatment and outcome of giant cell tumors of the pelvis.
Balke M; Streitbuerger A; Budny T; Henrichs M; Gosheger G; Hardes J
Acta Orthop; 2009 Oct; 80(5):590-6. PubMed ID: 19916695
[TBL] [Abstract][Full Text] [Related]
5. Wide resection versus curettage with adjuvant therapy for giant cell tumour of bone.
Kamal AF; Simbolon EL; Prabowo Y; Hutagalung EU
J Orthop Surg (Hong Kong); 2016 Aug; 24(2):228-31. PubMed ID: 27574268
[TBL] [Abstract][Full Text] [Related]
6. [Surgical treatment for long bone giant cell tumor of extremity with pathologic fracture].
Li X; Guo W; Yang Y; Wei R; DU ZY
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Oct; 45(5):745-51. PubMed ID: 24136271
[TBL] [Abstract][Full Text] [Related]
7. Segmental excision versus intralesional curettage with adjuvant therapy for giant cell tumour of bone.
Yacob O; Umer M; Gul M; Qadir I
J Orthop Surg (Hong Kong); 2016 Apr; 24(1):88-91. PubMed ID: 27122520
[TBL] [Abstract][Full Text] [Related]
8. Curettage and allograft reconstruction for giant cell tumours.
Morii T; Yabe H; Morioka H; Suzuki Y; Anazawa U; Toyama Y
J Orthop Surg (Hong Kong); 2008 Apr; 16(1):75-9. PubMed ID: 18453664
[TBL] [Abstract][Full Text] [Related]
9. Metachronous multicentric giant-cell tumour: a case report.
Sadat-Ali M
Indian J Cancer; 1997 Dec; 34(4):169-76. PubMed ID: 9715540
[TBL] [Abstract][Full Text] [Related]
10. Factors of local recurrence of giant cell tumor of long bone after treatment: plain radiographs, pathology and surgical procedures.
Chanchairujira K; Jiranantanakorn T; Phimolsarnti R; Asavamongkolkul A; Waikakul S
J Med Assoc Thai; 2011 Oct; 94(10):1230-7. PubMed ID: 22145509
[TBL] [Abstract][Full Text] [Related]
11. Long bones giant cells tumors: treatment by curretage and cavity filling cementation.
Fraquet N; Faizon G; Rosset P; Phillipeau J-; Waast D; Gouin F
Orthop Traumatol Surg Res; 2009 Oct; 95(6):402-6. PubMed ID: 19767256
[TBL] [Abstract][Full Text] [Related]
12. Is Navigation-guided En Bloc Resection Advantageous Compared With Intralesional Curettage for Locally Aggressive Bone Tumors?
Farfalli GL; Albergo JI; Piuzzi NS; Ayerza MA; Muscolo DL; Ritacco LE; Aponte-Tinao LA
Clin Orthop Relat Res; 2018 Mar; 476(3):511-517. PubMed ID: 29529633
[TBL] [Abstract][Full Text] [Related]
13. [The analysis of the treatment of giant cell tumor of the pelvis and sacrum].
Guo W; Tang XD; Li X; Ji T; Sun X
Zhonghua Wai Ke Za Zhi; 2008 Apr; 46(7):501-5. PubMed ID: 18785558
[TBL] [Abstract][Full Text] [Related]
14. Treatment of giant cell tumor of the distal radius.
Cheng CY; Shih HN; Hsu KY; Hsu RW
Clin Orthop Relat Res; 2001 Feb; (383):221-8. PubMed ID: 11210959
[TBL] [Abstract][Full Text] [Related]
15. Multicentric Giant Cell Tumor of Bone.
Errani C; Tsukamoto S; Angulo Alvarado R; Righi A; Nitta Y; Donati DM; Mavrogenis AF
Orthopedics; 2023; 46(6):e376-e380. PubMed ID: 37126833
[TBL] [Abstract][Full Text] [Related]
16. Extended curettage versus en bloc resection for the treatment of grade 3 giant cell tumour of the knee with pathologic fracture: a retrospective study.
Jamshidi K; Zandrahimi F; Haji Agha Bozorgi M; Arefpour AM; Bagherifard A; Al-Baseesee HH; Mirzaei A
Int Orthop; 2021 Jan; 45(1):289-297. PubMed ID: 33001283
[TBL] [Abstract][Full Text] [Related]
17. Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy.
Trieb K; Bitzan P; Lang S; Dominkus M; Kotz R
Eur J Surg Oncol; 2001 Mar; 27(2):200-2. PubMed ID: 11289759
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for local recurrence in extremity-located giant cell tumours of bone with pathological fracture.
Medellin MR; Fujiwara T; Tillman RM; Jeys LM; Gregory J; Stevenson JD; Parry M; Abudu A
Bone Joint J; 2018 Dec; 100-B(12):1626-1632. PubMed ID: 30499317
[TBL] [Abstract][Full Text] [Related]
19. An acetabular-preserving procedure for pelvic giant cell tumor involving partial acetabulum.
Xiao C; Zhou Y; Zhang W; Luo Y; Tu C
World J Surg Oncol; 2017 Nov; 15(1):200. PubMed ID: 29132434
[TBL] [Abstract][Full Text] [Related]
20. The role of Denosumab in joint preservation for patients with giant cell tumour of bone.
Perrin DL; Visgauss JD; Wilson DA; Griffin AM; Abdul Razak AR; Ferguson PC; Wunder JS
Bone Joint J; 2021 Jan; 103-B(1):184-191. PubMed ID: 33380180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
